Showing results (251-260 of 523) with videos related to
Sort By:
Pageof 53
Oncology|February 28, 2009
Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancersMaria S Pino, Michele Milella, Alain Gelibter, et al.Igiene E Sanita Pubblica|June 12, 2019
[Use of the Lean methodology in the management of cancer patients in a University Hospital, Italy: First results]Antonio Giulio De Belvis, Carmen Angioletti, Serena Traglia, et al.Annali Italiani Di Chirurgia|May 24, 2013
A case of oesophageal cancer with low back pain: the accidental finding of skeletal muscle metastasisGiovanni Leuzzi, Alfredo Cesario, Stefano Margaritora, et al.Anti-Cancer Drugs|March 8, 2006
Weekly paclitaxel, 5-fluorouracil and folinic acid with granulocyte colony-stimulating factor support in metastatic breast cancer patients: a phase II studyCecilia Nistico, Emilio Bria, Biagio Agostara, et al.Frontiers in Oncology|March 27, 2023
Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional responseMariangela Pasqualoni, Armando Orlandi, Antonella Palazzo, et al.Expert Review of Anticancer Therapy|June 21, 2022
Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areasLorenzo Belluomini, Alice Avancini, Luca Pasqualin, et al.Critical Reviews in Oncology/Hematology|June 23, 2019
Muscle derangement and alteration of the nutritional machinery in NSCLCIlaria Trestini, Anastasios Gkountakos, Luisa Carbognin, et al.Cancers|August 14, 2019
PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game AroundAnastasios Gkountakos, Giulia Sartori, Italia Falcone, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 31, 2010
Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapyMark G Kris, Maurizio Tonato, Emilio Bria, et al.Current Drug Targets|March 31, 2012
Molecular and genetic bases of pancreatic cancerVanja Vaccaro, Alain Gelibter, Emilio Bria, et al.Pageof 53